Differential Proinflammatory Signature in Vestibular Migraine and Meniere Disease
Metadata
Show full item recordAuthor
Flook, Marisa; Frejo, Lidia; Espinosa Sánchez, Juan Manuel; Pérez Carpena, Patricia; López Escámez, José AntonioEditorial
Frontiers in Media
Materia
Vestibular Migraine Meniere Disease Differential diagnosis
Date
2019-06-04Referencia bibliográfica
Flook M, Frejo L, Gallego-Martinez A, Martin-Sanz E, Rossi-Izquierdo M, Amor-Dorado JC, Soto-Varela A, Santos-Perez S, Batuecas-Caletrio A, Espinosa-Sanchez JM, Pérez-Carpena P, Martinez-Martinez M, Aran I and Lopez-Escamez JA (2019) Differential Proinflammatory Signature in Vestibular Migraine and Meniere Disease. Front. Immunol. 10:1229.
Sponsorship
This work was supported by PI13/1242 and PI17/1644 Grant from ISCIII by FEDER Funds from the EU. Marisa Flook is funded by FI18/00228 from ISCIII.Abstract
Vestibular Migraine (VM) and Meniere’s Disease (MD) are episodic vestibular syndromes
defined by a set of associated symptoms such as tinnitus, hearing loss or migraine
features during the attacks. Both conditions may show symptom overlap and there is
no biological marker to distinguish them. Two subgroups of MD patients have been
reported, according to their IL-1b profile. Therefore, considering the clinical similarity
between VM and MD, we aimed to investigate the cytokine profile of MD and VM
as a means to distinguish these patients. We have also carried out gene expression
microarrays and measured the levels of 14 cytokines and 11 chemokines in 129 MD
patients, 82 VM patients, and 66 healthy controls. Gene expression profile in peripheral
blood mononuclear cells (PBMC) showed significant differences in MD patients with high
and low basal levels of IL- 1b and VMpatients.MD patients with high basal levels of IL- 1b
(MDH) had overall higher levels of cytokines/chemokines when compared to the other
subsets. CCL4 levels were significantly different between MDH, MD with low basal levels
of IL- 1b (MDL), VM and controls. Logistic regression identified IL- 1b, CCL3, CCL22, and
CXCL1 levels as capable of differentiating VM patients from MD patients (area under the
curve = 0.995), suggesting a high diagnostic value in patients with symptoms overlap.